Purpose of this Study
We are doing this study to collect information about people with oligometastasis for future use.
Who Can Participate?
Eligibility
Adults who:
-Have cancer that has spread to other parts of the body
-Planning to undergo ablative radiotherapy
-Have cancer that has spread to other parts of the body
-Planning to undergo ablative radiotherapy
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
If you decide to join this study you will come in for one visit to let us collect data about you, your disease and your treatment.
Locations
Remote/online
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Principal Investigator
Joseph
Salama
Protocol Number
PRO00103137
NCT ID
NCT04085029
Phase
N/A
Enrollment Status
OPEN TO ACCRUAL